The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers.

De Mattos-Arruda, Leticia; Cortes, Javier; Blanco-Heredia, Juan; Tiezzi, Daniel G; Villacampa, Guillermo; Gonçalves-Ribeiro, Samuel; Paré, Laia; Souza, Carla Anjos; Ortega, Vanesa; Sammut, Stephen-John; Cusco, Pol; Fasani, Roberta; Chin, Suet-Feung; Perez-Garcia, Jose; Dienstmann, Rodrigo; Nuciforo, Paolo; Villagrasa, Patricia; Rubio, Isabel T; Prat, Aleix; Caldas, Carlos

De Mattos-Arruda, Leticia; Cortes, Javier; Blanco-Heredia, Juan; Tiezzi, Daniel G; Villacampa, Guillermo; Gonçalves-Ribeiro, Samuel; Paré, Laia; Souza, Carla Anjos; Ortega, Vanesa; Sammut, Stephen-John; Cusco, Pol; Fasani, Roberta; Chin, Suet-Feung; Perez-Garcia, Jose; Dienstmann, Rodrigo; Nuciforo, Paolo; Villagrasa, Patricia; Rubio, Isabel T; Prat, Aleix; Caldas, Carlos.

Afiliación

De Mattos-Arruda L; IrsiCaixa, Germans Trias i Pujol University Hospital, Badalona, Spain. ldemattos@irsicaixa.es.
Cortes J; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain. ldemattos@irsicaixa.es.
Blanco-Heredia J; Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, UK. ldemattos@irsicaixa.es.
Tiezzi DG; Oncology Department International Breast Cancer Center (IBCC), Quiron Group, Barcelona, Spain.
Villacampa G; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.
Gonçalves-Ribeiro S; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA.
Paré L; Breast Cancer Research program, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Souza CA; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain.
Ortega V; IrsiCaixa, Germans Trias i Pujol University Hospital, Badalona, Spain.
Sammut SJ; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
Cusco P; Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, UK.
Fasani R; Breast Disease Division, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil.
Chin SF; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.
Perez-Garcia J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.
Dienstmann R; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.
Nuciforo P; SOLTI Breast Cancer Research Group, Barcelona, Spain.
Villagrasa P; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
Rubio IT; IrsiCaixa, Germans Trias i Pujol University Hospital, Badalona, Spain.
Prat A; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
Caldas C; Breast Cancer Research program, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain.

NPJ Breast Cancer ; 7(1): 73, 2021 Jun 07.

Article en En | MEDLINE | ID: mdl-34099718

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: NPJ Breast Cancer Año: 2021 Tipo del documento: Article País de afiliación: España

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google